Organon Usa Inc Drug Patent Portfolio
Organon Usa Inc owns 3 orange book drugs protected by 5 US patents Given below is the list of Organon Usa Inc's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7446090 | FSH formulation | 23 Aug, 2019 | Expired |
| US7563763 | FSH and FSH variant formulations, products and methods | 23 Aug, 2019 | Expired |
| US5929028 | Liquid gonadotropin containing formulations | 14 Jan, 2018 | Expired |
| US5767251 | Recombinant heterodimeric human fertility hormones, and methods, cells, and vectors and DNA for the production thereof | 16 Jun, 2015 | Expired |
| US5418226 | Monoquaternary 2,16-bispiperidinylandrostane derivatives | 14 Apr, 2013 | Expired |
Latest Legal Activities on Organon Usa Inc's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Organon Usa Inc.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Expire Patent
Critical
| 23 Aug, 2021 | US7563763 |
|
Maintenance Fee Reminder Mailed
Critical
| 08 Mar, 2021 | US7563763 |
|
Expire Patent
Critical
| 07 Dec, 2020 | US7446090 |
|
Maintenance Fee Reminder Mailed
Critical
| 22 Jun, 2020 | US7446090 |
| Post Issue Communication - Certificate of Correction | 05 Aug, 2009 | US7446090 |
| Post Issue Communication - Certificate of Correction | 31 Jul, 2009 | US7563763 |
| Sequence Moved to Public Database | 30 Jul, 2009 | US7563763 |
|
Recordation of Patent Grant Mailed
Critical
| 21 Jul, 2009 | US7563763 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 21 Jul, 2009 | US7563763 |
|
Issue Notification Mailed
Critical
| 01 Jul, 2009 | US7563763 |
| Dispatch to FDC | 16 Jun, 2009 | US7563763 |
|
Mail Response to 312 Amendment (PTO-271)
Critical
| 16 Jun, 2009 | US7563763 |
| Mail-Petition Decision - Granted | 15 Jun, 2009 | US7563763 |
|
Petition Decision - Granted
Critical
| 15 Jun, 2009 | US7563763 |
| Filing Receipt - Corrected | 15 Jun, 2009 | US7563763 |
Organon Usa Inc's Family Patents
Organon Usa Inc Drug List
Given below is the complete list of Organon Usa Inc's drugs and the patents protecting them.
1. Follistim
Follistim is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5767251 | Recombinant heterodimeric human fertility hormones, and methods, cells, and vectors and DNA for the production thereof |
16 Jun, 2015
(9 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Follistim's drug page
2. Follistim Aq
Follistim Aq is protected by 4 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7446090 | FSH formulation |
23 Aug, 2019
(5 years ago)
| Expired |
| US7563763 | FSH and FSH variant formulations, products and methods |
23 Aug, 2019
(5 years ago)
| Expired |
| US5929028 | Liquid gonadotropin containing formulations |
14 Jan, 2018
(6 years ago)
| Expired |
| US5767251 | Recombinant heterodimeric human fertility hormones, and methods, cells, and vectors and DNA for the production thereof |
16 Jun, 2015
(9 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Follistim Aq's drug page
3. Raplon
Raplon is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5418226 | Monoquaternary 2,16-bispiperidinylandrostane derivatives |
14 Apr, 2013
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Raplon's drug page